Simplex Trading
HRMY icon

Simplex Trading’s Harmony Biosciences HRMY Stock Holding History

Simplex Trading’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Buy
+360
New +$11.4K ﹤0.01% 7468
2025
Q4 		– Sell
-6,003
Closed -$165K – 9189
2025
Q3 		$165K Buy
+6,003
New +$207K ﹤0.01% 5167
2024
Q3 		– Sell
-5,569
Closed -$196K – 8936
2024
Q2 		$168K Buy
+5,569
New +$167K ﹤0.01% 4820
2023
Q4 		– Sell
-1,914
Closed -$53.4K – 9235
2023
Q3 		$62K Buy
1,914
+1,736
+975% +$60.3K ﹤0.01% 5597
2023
Q2 		$6K Buy
+178
New +$6.14K ﹤0.01% 7791
2022
Q4 		– Sell
-730
Closed -$40.1K – 9685
2022
Q3 		$32K Buy
730
+18
+3% +$878 ﹤0.01% 6991
2022
Q2 		$34K Buy
712
+612
+612% +$27.6K ﹤0.01% 6980
2022
Q1 		$4K Buy
+100
New +$4.08K ﹤0.01% 9562

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's HRMY Position: Q2 2026 in Review

Simplex Trading opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 360 shares worth $13.1K. The stake represents ﹤0.01% of the portfolio and ranks #7468 among its holdings. This is a return to the name: Simplex Trading previously reported a position in HRMY as recently as Q3 2025.

Simplex Trading first reported a position in HRMY in Q1 2022 and has held it in 8 quarters since. The position peaked at $168K in Q2 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Simplex Trading held 360 shares of Harmony Biosciences worth $13.1K as of Q2 2026.
  • Harmony Biosciences was a new Simplex Trading position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7468 holding.
  • Simplex Trading first reported a position in Harmony Biosciences in Q1 2022 and has held it in 8 quarters since.
  • Simplex Trading's Harmony Biosciences position peaked at $168K in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.